BIOGEN INC. (BIIB)
Clinical trial NCT06962800 updates: 1. completion date: 2029-03-29 → 2031-01-17 2. primary completion date: 2028-12-29 → 2030-01-28
Clinical trial NCT06962800 updates: 1. completion date: 2029-03-29 → 2031-01-17 2. primary completion date: 2028-12-29 → 2030-01-28
📉 **NEGATIVE** • Medium confidence analysis (69%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (20%) **Content type:** Clinical